8-03-2023, 06:01

MacroGenics Announces Date of Fourth Quarter 2022 Financial

ROCKVILLE, MD, March 07, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company
Globe Newswire8-03-2023, 06:01
6-03-2023, 02:01

Additional Data on Lumos OraGrowtH Trials Presented

Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data
Globe Newswire6-03-2023, 02:01
2-03-2023, 19:18

Aurora Spine Receives IRB Approval To Commence Multicenter

CARLSBAD, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:
Globe Newswire2-03-2023, 19:18
1-03-2023, 04:54

Rapid Micro Biosystems to Participate in the Cowen 43rd

LOWELL, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an
Globe Newswire1-03-2023, 04:54
17-02-2023, 04:08

Rapid Micro Biosystems to Announce Fourth Quarter and Full

LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an
Globe Newswire17-02-2023, 04:08
7-02-2023, 04:59

MacroGenics to Participate in Upcoming Investor

ROCKVILLE, MD, Feb. 06, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused
Globe Newswire7-02-2023, 04:59